Business Description
Meridian Bioscience Inc
NAICS : 325413
SIC : 2835
ISIN : US5895841014
Share Class Description:
VIVO: Ordinary SharesDescription
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 4.9 | |||||
| 12-1 Month Momentum % | 59.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | 22.14 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-Revenue | 5.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VIVO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Meridian Bioscience Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 333.018 | ||
| EPS (TTM) ($) | 0.96 | ||
| Beta | 0 | ||
| Volatility % | 22.53 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.11 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 59.28 | ||
| 52-Week Range ($) | 20.35 - 34.375 | ||
| Shares Outstanding (Mil) | 44.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Meridian Bioscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Meridian Bioscience Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Meridian Bioscience Inc Frequently Asked Questions
What is Meridian Bioscience Inc(VIVO)'s stock price today?
The current price of VIVO is $33.97. The 52 week high of VIVO is $34.38 and 52 week low is $20.35.
When is next earnings date of Meridian Bioscience Inc(VIVO)?
The next earnings date of Meridian Bioscience Inc(VIVO) is 2024-05-05 Est..
Does Meridian Bioscience Inc(VIVO) pay dividends? If so, how much?
Meridian Bioscience Inc(VIVO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers